Chaos In Washington Raises Shutdown Fears, PBM And Rare Disease Priorities Cut From CR

 
• By Sarah Karlin-Smith and Derrick Gingery
  
picture of person in business suit shredding paper
Pharma priorities like PBM reform may be left on cutting room floor as Congress tries to avert a government shutdown. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legislation

More from Pink Sheet